A comparative study of new medications for psychosis in adolescents

Trial Profile

A comparative study of new medications for psychosis in adolescents

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Olanzapine; Quetiapine; Risperidone
  • Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Mar 2009 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 15 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top